Pediatric Oncology Imaging Guidelines

Covers appropriate use of diagnostic, staging, treatment‑response, and surveillance imaging (CT, MRI, ultrasound, nuclear medicine/PET) for pediatric patients (<18 years at initial diagnosis) with pediatric cancers and cancer‑predisposition syndromes — e.g., leukemias, CNS tumors, lymphomas, neuroblastoma, renal, soft tissue, bone, germ cell, liver, retinoblastoma, and long‑term survivors. Major requirements/limits include age‑based guideline assignment, a recent (within 60 days) history/physical and laboratory evaluation prior to advanced imaging (except scheduled off‑therapy surveillance), avoidance of routine advanced imaging without localizing signs or abnormal radiography/ultrasound, staging generally before treatment starts, treatment‑response imaging typically no more often than every two cycles, PET/surveillance only when specifically supported, and physician review for atypical presentations.

"This tool addresses common symptoms and symptom complexes."